Group Leader
Carlos Molina Cateriano
Principal Investigator (PI)
Estela Sanjuan, Marta Rubiera, David Rodríguez, Estefania Montiel, Jorge Pagola, Manuel Requena, Marc Ribó, Marta Olivé, María Ángeles Muchada
Researchers
Alejandro Tomasello, Jesús Juega, Jiahui Li, Noelia Rodríguez, Olalla Pancorbo
PhD Students
Federica Rizzo, María Belén Taborda, Pere Canals
Nursing and Technical Staff
Claudia Meza, María Victoria Sala, Carole Conforti, Cristina Losada, David Cano, Ester Sánchez, Judith Cendrero, Lidia García, Marc Molina, María Baladas, Cristina Guirao, Carolina Paredes, Riccardo Tiberi, Maria Franco, Jordi Brunet
50
PUBLICATIONS
58.0%
%Q1
1,089
IMPACT FACTOR
21.78
AVERAGE IMPACT FACTOR
SELECTED ARTICLES
Pérez de la Ossa N, Abilleira S, Jovin TG, García-Tornel Á, Jimenez X, Urra X, Cardona P, Cocho D, Purroy F, Serena J, San Román Manzanera L, Vivanco-Hidalgo RM, Salvat-Plana M, Chamorro A, Gallofré M, Molina CA, Cobo E, Davalos A, Ribo M
Effect of Direct Transportation to Thrombectomy-Capable Center vs Local Stroke Center on Neurological Outcomes in Patients With Suspected Large-Vessel Occlusion Stroke in Nonurban Areas: The RACECAT Randomized Clinical Trial
JAMA. 2022 May 10;327(18):1782-1794
DOI: doi: 10.1001/jama.2022.4404
IF: 157.375
Renú A, Millán M, San Román L, Blasco J, Martí-Fàbregas J, Terceño M, Amaro S, Serena J, Urra X, Laredo C, Barranco R, Camps-Renom P, Zarco F, Oleaga L, Cardona P, Castaño C, Macho J, Cuadrado-Godía E, Vivas E, López-Rueda A, Guimaraens L, Ramos-Pachón A, Roquer J, Muchada M, Tomasello A, Dávalos A, Torres F, Chamorro Á
Effect of Intra-arterial Alteplase vs Placebo Following Successful Thrombectomy on Functional Outcomes in Patients With Large Vessel Occlusion Acute Ischemic Stroke: The CHOICE Randomized Clinical Trial
JAMA. 2022 Mar 1;327(9):826-835
DOI: doi: 10.1001/jama.2022.1645
IF: 157.375
Jovin TG, Li C, Wu L, Wu C, Chen J, Jiang C, Shi Z, Gao Z, Song C, Chen W, Peng Y, Yao C, Wei M, Li T, Wei L, Xiao G, Yang H, Ren M, Duan J, Liu X, Yang Q, Liu Y, Zhu Q, Shi W, Zhu Q, Li X, Guo Z, Yang Q, Hou C, Zhao W, Ma Q, Zhang Y, Jiao L, Zhang H, Liebeskind DS, Liang H, Jadhav AP, Wen C, Brown S, Zhu L, Ye H, Ribo M, Chang M, Song H, Chen J, Ji X
Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion
N Engl J Med. 2022 Oct 13;387(15):1373-1384
DOI: doi: 10.1056/NEJMoa2207576
IF: 176.082
Fischer U, Kaesmacher J, Strbian D, Eker O, Cognard C, Plattner PS, Bütikofer L, Mordasini P, Deppeler S, Pereira VM, Albucher JF, Darcourt J, Bourcier R, Benoit G, Papagiannaki C, Ozkul-Wermester O, Sibolt G, Tiainen M, Gory B, Richard S, Liman J, Ernst MS, Boulanger M, Barbier C, Mechtouff L, Zhang L, Marnat G, Sibon I, Nikoubashman O, Reich A, Consoli A, Lapergue B, Ribo M, Tomasello A, Saleme S, Macian F, Moulin S, Pagano P, Saliou G, Carrera E, Janot K, Hernández-Pérez M, Pop R, Schiava LD, Luft AR, Piotin M, Gentric JC, Pikula A, Pfeilschifter W, Arnold M, Siddiqui AH, Froehler MT, Furlan AJ, Chapot R, Wiesmann M, Machi P, Diener HC, Kulcsar Z, Bonati LH, Bassetti CL, Mazighi M, Liebeskind DS, Saver JL, Gralla J
Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial
Lancet. 2022 Jul 9;400(10346):104-115
DOI: doi: 10.1016/S0140-6736(22)00537-2
IF: 202.731
Jovin TG, Nogueira RG, Lansberg MG, Demchuk AM, Martins SO, Mocco J, Ribo M, Jadhav AP, Ortega-Gutierrez S, Hill MD, Lima FO, Haussen DC, Brown S, Goyal M, Siddiqui AH, Heit JJ, Menon BK, Kemp S, Budzik R, Urra X, Marks MP, Costalat V, Liebeskind DS, Albers GW
Thrombectomy for anterior circulation stroke beyond 6 h from time last known well (AURORA): a systematic review and individual patient data meta-analysis
Lancet. 2022 Jan 15;399(10321):249-258
DOI: doi: 10.1016/S0140-6736(21)01341-6
IF: 202.731
HARMONICS. Harmonization and Implementation of High Value Stroke Care
Principal Investigator: Carlos Molina
Agency: European Commission
Funding: 468,090€
Period: 01/01/2022 - 31/12/2024
Clinical trial to evaluate the administration of ApTOLL in ambulances and the neuroprotective effect in stroke patients. RACETOLL
Principal Investigator: Marc Ribó
Agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 437,334€
Period: 01/03/2022 - 28/02/2025
: RES-Q PLUS: Comprehensive solutions of healthcare improvement based on the global Registry of Stroke Care Quality
Principal Investigator: Carlos Molina
Agency: European Commission
Funding: 396,730€
Period: 01/10/2022 - 30/09/2026
Ensayo Clínico para evaluar biomarcadores de efecto neuroprotector de ApTOLL en pacientes de Ictus Isquémico Agudo
Principal Investigator: Marc Ribó
Agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 391,911.2€
Period: 01/10/2020 - 31/03/2023
VALIDATE: Validation of a Trustworthy AI-based Clinical Decision Support System for Improving Patient Outcome in Acute Stroke Treatment
Principal Investigator: Marta Rubiera
Agency: European Commission
Funding: 567,950€
Period: 01/05/2022 - 30/04/2026